Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.

@article{Wang2001ResistanceO,
  title={Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.},
  author={Wenli Wang and Steven M. Larson and Robert Michael Tuttle and Hovanes Kalaigian and Katherine Kolbert and Martin Sonenberg and Richard J. Robbins},
  journal={Thyroid : official journal of the American Thyroid Association},
  year={2001},
  volume={11 12},
  pages={
          1169-75
        }
}
Radioactive iodine (131I) is an important therapeutic option for the treatment of metastatic thyroid carcinoma. Survival in patients with metastases that concentrate radioiodine is better than those whose metastatic lesions do not take up radioiodine. Survival is markedly reduced in patients who have metastatic lesions that concentrate 18F-fluorodeoxyglucose (FDG) on positron emission tomography (PET). In this retrospective study, we evaluated the ability of 131I to destroy FDG-avid metastatic… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 53 CITATIONS

Similar Papers

Loading similar papers…